Polycystic Ovary Syndrome and Medical Therapies for Acne and Hirsutism

In this presentation, dermatologist Rachel Reynolds focuses on Polycystic Ovary Syndrome (PCOS) and its impact on skin conditions like acne and hirsutism. PCOS is characterized by hormonal imbalances that often result in acne, hirsutism, and menstrual irregularities, posing risks for long-term health issues. The diagnosis relies on clinical criteria emphasizing oligo- or anovulation, hyperandrogenism, and the presence of polycystic ovaries. Reynolds discusses the clinical symptoms, including the prevalence of severe acne among women with PCOS, often treated with hormonal therapies. Treatment plans typically include lifestyle changes, weight management, contraceptive pills to regulate menstrual cycles, and medications like spironolactone, which help reduce androgen levels and improve quality of life. The connection between insulin resistance and PCOS is highlighted, stressing the importance of managing metabolic health. Reynolds notes that hormonal therapies can effectively treat acne in both PCOS and non-PCOS patients, advocating for a shift away from extensive antibiotic use. Furthermore, the recent data concerning spironolactone indicates it poses no significant cancer risk, and potassium monitoring is only necessary in specific populations. Overall, a multi-modal approach to treatment is critical, combining medication with lifestyle changes for optimal patient care.